Prescription Drug Search
Product Request Form
Alemtuzumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Alemtuzumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about NationDrugs.to
List of countries where we can ship Alemtuzumab:
- Albania
- Bangladesh
- Belarus
- Bolivia
- Brazil
- Cayman Islands
- Colombia
- Cook Islands
- Costa Rica
- Croatia
- Cuba
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- Finland
- Greece
- India
- Iraq
- Jordan
- Lebanon
- Malta
- Monaco
- Morocco
- Netherlands
- New Zealand
- Nicaragua
- Peru
- Poland
- Qatar
- Romania
- Saint Lucia
- Saudi Arabia
- Seychelles
- South Africa
- Spain
- Tunisia
- Ukraine
- United Kingdom, UK
- United States, US
Latest news releases on Alemtuzumab:
Alemtuzumab - Wikipedia
L'alemtuzumab è un anticorpo monoclonale umanizzato utilizzato contro la leucemia linfatica cronica. Per il suo meccanismo di azione favorisce la riuscita della lisi ...
Alemtuzumab (Campath) - Medical Clinical Policy Bulletins ...
Number: 0764. Policy. Aetna considers alemtuzumab (Campath) medically necessary for the treatment of any of the following conditions:
Alemtuzumab to Treat Severe Aplastic Anemia - Full Text ...
This study will evaluate the safety and usefulness of a new immunosuppressive drug, alemtuzumab (Campath ), in patients with severe aplastic anemia (SAA). SAA is a ...
Campath (ALEMTUZUMAB) Package Insert
Return to Table of Contents. Campath ® (ALEMTUZUMAB) DESCRIPTION. Campath ® (Alemtuzumab) is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H ...
Alemtuzumab CARE-MS Trials Published - Latest Medical News ...
Full results of phase 3 trials of alemtuzumab confirm reductions in relapse rates in patients with MS, and in 1 trial, reduction in sustained accumulation of ...
Relapsing MS Infusion Treatment | LEMTRADA® (alemtuzumab)
Get to know LEMTRADA, an infusion therapy for relapsing multiple sclerosis (MS). Hear from patients and HCPs, find helpful resources and locate relapsing MS events ...
Informationen zum kostenfreien Bezug von MabCampath ...
Informationen zum kostenfreien Bezug von MabCampath (Alemtuzumab) nach Rücknahme der Zulassung. Nach der europaweiten Rücknahme der Zulassung von MabCampath ...
Alemtuzumab para la esclerosis múltiple | Cochrane
En los pacientes con EM recurrente-remitente, el alemtuzumab 12 mg fue mejor que el interferón beta-1a subcutáneo para los siguiente resultados evaluados a los 24 ...
LEMTRADA 12 mg concentrate for solution for infusion ...
Each vial contains 12 mg alemtuzumab in 1.2 ml (10 mg/ml). Alemtuzumab is a monoclonal antibody produced in mammalian cell (Chinese Hamster Ovary) suspension culture ...
MS hastalığı tedavisinde yeni umut: Alemtuzumab
Alemtubumab tedavisi MS hastalığının tedavisinde çözüm sunuyor. Peki Alemtuzumab nedir? Alemtuzumab tedavisi nasıl uygulanır, nerede uygulanır?
